Sacramento, CA – U.S. Senate candidate Carly Fiorina today issued the following statement after the Senate voted along party lines to move forward with Democrats’ costly and flawed health care reform legislation:
“This health care reform legislation is a huge step backward for California. In addition to raising taxes on the middle class, this big-government bill saddles our state budget with an additional $3 billion burden that California taxpayers simply cannot afford.
“The debate about health care reform is a perfect example of how decisions made by the U.S. Senate impact every family and every business in America. Senator Boxer has not lifted a finger to reduce the financial burden this bill will have on our state and on taxpayers. Instead, she has been a reliable and consistent partisan vote for more government spending and higher taxes throughout this process. With her vote last night, Barbara Boxer proved yet again that her loyalties lie with the special interests, not with the people of California
“Barbara Boxer must be held accountable for her dismal record – a record that has consistently put the Californians she represents last and her own political ambitions first. I am running for U.S. Senate because California deserves better representation in our nation’s capital; it’s time for a change.”
Fiorina does not support the Senate health care reform bill and believes that any health reform legislation should focus first and foremost on keeping decisions about care between doctors and patients and it should build on ideas that we know from experience work, such as:
- Building on programs that provide incentives for receiving preventative care and for healthy lifestyles.
- Reforming malpractice on a national level as has been done in California.
- Providing greater access to lower-cost community-based primary care clinics.
- Encouraging more transparency about pricing and quality of healthcare services.
- Allowing consumers to purchase any health plan from anywhere in the country.
- Creating more market-based competition for everything from health insurance to prescription drugs.
